September 27, 2026 · AxonCPT Team · telehealth, clinical practice, adult ADHD

Can PMHNPs Prescribe Stimulants via Telehealth? By State

Yes, a PMHNP can prescribe stimulants via telehealth in many states, but it depends on the state where the patient is located, not only the state where you live. You need an APRN license and prescriptive authority in the patient’s state, Schedule II authority under that state’s law, any required collaborative or supervisory agreement, a DEA registration that covers that state, and compliance with that state’s PDMP and telehealth rules. The federal DEA telemedicine flexibilities, in effect through December 31, 2026, sit on top of all that [1]. They don’t override state limits.

Map of the United States with pins marking different states Photo by Joey Csunyo on Unsplash

This post gives you a framework for checking any state, with a few examples sourced from state statutes and official boards. It deliberately does not include a 50-state table. State rules change often, and an unsourced table would mislead you. Current as of September 27, 2026. This is not legal advice: verify every point with the state board of nursing, the state controlled-substance authority, and healthcare counsel before prescribing to patients in a new state. For defensible remote documentation, objective ADHD testing with AxonCPT is one tool; the framework applies whatever you use.

The six questions to answer for each state

Work through these for every state where you have, or plan to have, patients:

# Question Where to check
1 Do I hold an APRN license in the patient’s state? State board of nursing
2 What is the state’s NP practice environment: full, reduced, or restricted? AANP State Practice Environment map [2], then the board
3 Can NPs prescribe Schedule II drugs here, and in what settings or under what limits? State nurse practice act, board rules
4 Is a collaborative, supervisory, or transition-to-practice agreement required, and does it have to cover controlled substances or telehealth? Board of nursing and board of medicine
5 Do I have a DEA registration covering this state, plus any required state controlled-substance registration? DEA Diversion Control; state CSR authority
6 What are the state’s PDMP enrollment and query rules, and any telehealth-specific prescribing rules? PDMP TTAC state profiles [3]; state telehealth law

If any answer is “no” or “unclear,” don’t prescribe Schedule II stimulants to patients located in that state until it is resolved.

1. Licensure: the patient’s location controls

Telehealth practice generally happens where the patient is. A multistate RN license does not solve this for PMHNPs. The Nurse Licensure Compact states that it “pertains to RN and LPN/VN licenses only. An APRN must hold an individual APRN license in each state of APRN practice” [4]. A separate APRN Compact has been created, but it only takes effect once enough states enact it. Check its current status rather than assuming it applies to you.

2. Practice environment: full, reduced, restricted

AANP groups states into three categories [2]:

  • Full practice: state law lets NPs evaluate, diagnose, order tests, and “initiate and manage treatments, including prescribing medications and controlled substances, under the exclusive licensure authority of the state board of nursing.”
  • Reduced practice: state law reduces at least one element of NP practice, for example by requiring a career-long collaborative agreement or limiting practice settings.
  • Restricted practice: state law restricts at least one element of NP practice by requiring career-long supervision, delegation, or team management.

This is a useful first filter, but it doesn’t answer the stimulant question. A state can be “full practice” in general and still have transition-to-practice hours, and a “reduced” or “restricted” state can have specific Schedule II rules. Always go to question 3.

3. Schedule II authority: the question that matters for stimulants

ADHD stimulants such as amphetamine and methylphenidate products are Schedule II, so general prescriptive authority is not enough. Three examples show how much state rules differ:

Texas: Schedule II delegation limited to specific settings. Under Texas Occupations Code §157.0511(b-1), a physician may delegate Schedule II prescribing to an APRN only in a hospital facility-based practice or as part of hospice care [5]. For an outpatient telehealth PMHNP, that generally means no Schedule II stimulant prescribing to patients located in Texas. Confirm with the Texas Board of Nursing and counsel.

Florida: a psychiatric-nurse exception to a supply limit. Florida’s APRN formulary must limit Schedule II prescribing to a 7-day supply, “except that such restriction does not apply to controlled substances that are psychiatric medications prescribed by psychiatric nurses as defined in s. 394.455” (Fla. Stat. §464.012(6)(a), 2025) [6]. Whether you meet the statutory definition of a psychiatric nurse is a question for the Florida Board of Nursing.

California: two new NP categories. Under AB 890, a “103 NP” “must work in a group setting with at least one physician and surgeon,” while a “104 NP” “may work independently within the population focus of their National Certification” after further practice time [7]. Other NPs continue to practice under standardized procedures. Which category you hold determines how you can structure a telehealth practice in California.

These are examples, not a survey. Check your own states directly.

Try it with your next patient. AxonCPT gives you 2 free tests every month — no card required. Send a link, your patient finishes in ~16 minutes from home, and you get a norm-referenced report instantly. Create your free account →

4. Collaborative and supervisory agreements

In reduced and restricted states, check four things in the agreement:

  • Does it cover controlled substances, and Schedule II specifically?
  • Does it cover telehealth and patients outside your physical location?
  • Must the collaborating physician be licensed in the patient’s state?
  • Does it require chart review, prescribing protocols, or limits you must document?

A collaborative agreement that works for in-person care in one state may not cover telehealth patients in another.

5. DEA registration in each state

DEA registration is location-specific. Federal regulations require “a separate registration… for each principal place of business or professional practice… where controlled substances are… dispensed” (21 CFR 1301.12(a)) [8]. In practice, telehealth prescribers generally need a DEA registration in each state where their patients are located. Legal analysis of DEA’s 2025 proposed special registration rule notes that it would keep that requirement while adding a lower-cost state telemedicine registration [9]. Many states also require a separate state controlled-substance registration. Confirm your registrations with DEA and each state.

The federal timeline is its own layer. See our guides to DEA telemedicine rules for 2027 and DEA special registration for telemedicine.

6. PDMP and state telehealth prescribing rules

PDMP rules differ by state: who must enroll, when to query, and how often. The PDMP Training and Technical Assistance Center keeps a list of mandatory query conditions with state citations [3]. Under the DEA’s proposed permanent framework, PDMP checks would also expand to multiple states [1]. Some states also have their own telehealth rules for controlled substances, such as in-person visit or informed-consent requirements. Check the state’s telehealth statute and board guidance.

How this looks in practice

A compliant telehealth ADHD workflow for a PMHNP licensed in several states:

  1. Confirm the patient’s location at every visit and document it. Stop if the patient is in a state where you lack authority.
  2. Run the six-question check once per state, and keep a dated memo with links to the statutes and board pages you relied on. Re-check at least annually.
  3. Evaluate thoroughly by video. See our guide to running a telehealth ADHD evaluation.
  4. Add objective data. With AxonCPT, you send a link and the patient completes the test at home in about 16 minutes, with no app or login. You get an instant report with five metrics compared against age- and sex-matched norms from a 20,000+ reference dataset. See what the report looks like.
  5. Document the prescribing decision to the standard in our ADHD documentation for stimulant prescribing guide, including the PDMP check for the patient’s state.

Frequently asked questions

Can a PMHNP prescribe Adderall via telehealth? Through December 31, 2026, federal DEA flexibilities allow Schedule II telemedicine prescribing without a prior in-person visit when their conditions are met [1]. State law must also allow a PMHNP to prescribe Schedule II drugs to a patient in that state, and some states restrict it [5].

Do I need a DEA registration in every state where my patients live? Generally, yes. DEA registration is tied to location [8], and the proposed special registration rule would keep a per-state requirement [9]. Confirm with DEA and counsel for your situation.

Does full practice authority mean I can prescribe stimulants anywhere? No. Full practice status applies only in that state, and you still need a license, DEA registration, and PDMP compliance for each state where patients are located [2][3].

Is there an official 50-state list of NP Schedule II authority? AANP’s practice environment map and state fact sheets are a starting point [2], but the binding sources are each state’s statutes and board rules. Verify with the board.

Start testing your patients with AxonCPT

Multistate telehealth prescribing raises the bar for documentation in every state you work in. AxonCPT gives PMHNPs a remote, norm-referenced attention measure that patients complete at home, so each Schedule II decision rests on more than self-report. You get 2 free tests every month, with no card required. Create your free AxonCPT account or learn more at axoncpt.com.

References

  1. Drug Enforcement Administration & Department of Health and Human Services. Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications. Federal Register, December 31, 2025. See also the proposed rule, Special Registrations for Telemedicine and Limited State Telemedicine Registrations, January 17, 2025.
  2. American Association of Nurse Practitioners. State Practice Environment. Updated May 2026.
  3. PDMP Training and Technical Assistance Center. State profiles and Mandatory PDMP query conditions (printed October 29, 2025).
  4. NCSBN Nurse Licensure Compact. FAQs. Accessed September 27, 2026.
  5. Texas Occupations Code §157.0511, Delegation of prescribing and ordering drugs and devices. Accessed September 27, 2026.
  6. Florida Statutes (2025). §464.012, Licensure of advanced practice registered nurses.
  7. California Board of Registered Nursing. Assembly Bill 890. Accessed September 27, 2026.
  8. Code of Federal Regulations. 21 CFR 1301.12 — Separate registrations for separate locations. Accessed September 27, 2026.
  9. Foley & Lardner LLP. DEA Unveils Long-Overdue Special Registration for Telemedicine in Proposed Rule. January 2025.